MedTrace Logo

In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin

NCT07194421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2025-09-26

No results posted yet for this study

Summary

This study evaluates a broad-spectrum SPF50+ sunscreen on 42 adults with Atopic Dermatitis, measuring skin tolerance and barrier function.

The study includes several visits as follow :

* Visit 1: Inclusion (Day 1)
* Visit 2: Intermediate Visit (Day 8)
* Visit 3: End of Study (Day 22)

Conditions

  • Atopic Dermatitis (AD)
  • SCORAD Index(15-25)

Interventions

OTHER

Sunscreen RV4620A RP2552

Dermo-cosmetic product, Broadspectrum Sunscreen RV4620A RP2552, very high protection product Instructions for product use given to the subjects: Apply before and during sun exposure, at least twice daily. During sun exposure, applications must be renewed as often as necessary, in particular after swimming, perspiring, towelling, in order to ensure a good protection. On days of bad weather, apply the product in the morning and at the beginning of the afternoon.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-10
Primary Completion
2024-02-09
Completion
2024-02-09

Countries

  • Mauritius

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07194421 on ClinicalTrials.gov